This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991:10:1-34.

Heparin-induced thrombocytopenia

T E Warkentin, J G Kelton

PMID: 1706880

Review

Heparin-induced thrombocytopenia

T E Warkentin et al. Prog Hemost Thromb. 1991.

. 1991:10:1-34.

Authors

T E Warkentin, J G Kelton

PMID: 1706880

No abstract available

PubMed Disclaimer

Similar articles

Heparin and platelets.
Warkentin TE, Kelton JG. Warkentin TE, et al. Hematol Oncol Clin North Am. 1990 Feb;4(1):243-64. Hematol Oncol Clin North Am. 1990. PMID: 1690205 Review.
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
Messmore HL, Griffin B, Koza M, Seghatchian J, Fareed J, Coyne E. Messmore HL, et al. Semin Thromb Hemost. 1991;17 Suppl 1:57-9. Semin Thromb Hemost. 1991. PMID: 1712512 Review.
Immune endothelial-cell injury in heparin-associated thrombocytopenia.
Cines DB, Tomaski A, Tannenbaum S. Cines DB, et al. N Engl J Med. 1987 Mar 5;316(10):581-9. doi: 10.1056/NEJM198703053161004. N Engl J Med. 1987. PMID: 3807952
Heparin-induced thrombocytopenia: use of indirect immunofluorescence.
Silberman S, Kovarik P. Silberman S, et al. Ann Clin Lab Sci. 1987 Mar-Apr;17(2):106-10. Ann Clin Lab Sci. 1987. PMID: 3555279
Heparin and its derivatives - present and future.
Harenberg J, Casu B. Harenberg J, et al. Thromb Haemost. 2009 Nov;102(5):801-3. doi: 10.1160/TH09-10-0698. Thromb Haemost. 2009. PMID: 19888511 No abstract available.

See all similar articles

Cited by

Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
Wilde MI, Markham A. Wilde MI, et al. Drugs. 1997 Dec;54(6):903-24. doi: 10.2165/00003495-199754060-00008. Drugs. 1997. PMID: 9421696 Review.
Heparin-induced thrombocytopenia: molecular pathogenesis.
Lee SH, Liu CY, PaoloVisentin G. Lee SH, et al. Int J Hematol. 2002 Aug;76 Suppl 1:346-51. doi: 10.1007/BF03165283. Int J Hematol. 2002. PMID: 12430880 Review.
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP, Ford SE, Scott JP, Aster RH. Visentin GP, et al. J Clin Invest. 1994 Jan;93(1):81-8. doi: 10.1172/JCI116987. J Clin Invest. 1994. PMID: 8282825 Free PMC article.
High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response.
Winder A, Shoenfeld Y, Hochman R, Keren G, Levy Y, Eldor A. Winder A, et al. J Clin Immunol. 1998 Sep;18(5):330-4. doi: 10.1023/a:1023238915316. J Clin Immunol. 1998. PMID: 9793825
Heparin-induced thrombocytopenia: acknowledging its presence in low-molecular weight heparin therapy.
Ng HJ, Lee LH. Ng HJ, et al. Int J Hematol. 2003 Feb;77(2):185-7. doi: 10.1007/BF02983219. Int J Hematol. 2003. PMID: 12627856

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information